Pharma

**Diabetes Epidemic Exposed: ADA Funded by Big Pharma**

by

Miami, Florida – The influence of big business on the American healthcare system can be seen through the American Diabetes Association (ADA), the leading diabetes advocacy and research non-profit in the United States. Diabetes affects millions of Americans, with over 100,000 deaths attributed to the disease each year, disproportionately impacting communities of color. The financial burden of diabetes, including medical expenses and treatment costs, totals around $400 billion annually, indicating a significant challenge in combating …

Read more

Antidepressant Ties Exposed: Top Psychiatrist Under Fire for Omitting Pharma Connections in Push for Over-The-Counter Meds

by

Boston, Massachusetts – The debate over whether antidepressants should be made available over-the-counter has sparked controversy, with critics accusing a Harvard psychiatrist of failing to disclose his financial ties to pharmaceutical companies. Dr. Roy Perlis, a professor of psychiatry at Harvard and a physician at Massachusetts General Hospital, recently penned an opinion piece advocating for easier access to mental health medication. Perlis argued that making antidepressants available over-the-counter could help individuals who are hesitant to …

Read more

**Access Denied**: Woman Suing Pharma Giants for Cheaper Medicine That Can Save Lives

by

South Africa – Cheri Nel, a patient with cystic fibrosis, is taking legal action against the pharmaceutical company Vertex in a bid to access the life-saving drug Trikafta. The medication, a “miracle drug,” has the potential to significantly improve the lives of individuals with cystic fibrosis, offering them a normal life expectancy and reducing the impact of frequent lung infections and hospital admissions. However, the exorbitant cost of $326,000 a year per patient makes it …

Read more

Weight-Loss Wonder Drug VK2735 Sends Viking Therapeutics Stock Soaring – Is a Big Pharma Takeover Next?

by

San Diego, California – Viking Therapeutics, a pharmaceutical company based in California, experienced a significant surge in its stock price this week following the announcement of positive results from a phase II clinical trial for a new weight-loss drug. The stock price more than doubled on Tuesday, reaching $85 per share, as investors cheered the promising trial outcomes. However, the stock saw a slight decline on Thursday, dropping by 15% to $80 per share after …

Read more

**Weight-loss drug market explodes with new liver disease treatment shaking up industry** **Liver Disease Treatment Trial Results Sends Zealand Pharma Shares Soaring – Could This Be the Next Big Weight Loss Drug?** **Liver Disease Treatment Breakthrough Rattles Pharma Industry: Is This the Future of Weight Loss Drugs?**

by

Hillerod, Denmark – The pharmaceutical industry has seen a surge in competition following the success of Novo Nordisk A/S’s weight-loss drugs, Ozempic and Wegovy. This success has prompted around 40 companies to develop products that aim to compete in this lucrative market. The production facilities in Hillerod, Denmark, are busy with vials moving along conveyors, symbolizing the bustling activity in the industry. Zealand Pharma, a Denmark-based company, experienced a significant increase in its stock value …

Read more

Amgen Stock: Is Weight-Loss Drug the Next Big Boon in Pharma?

by

CAMBRIDGE, Mass. – Amgen stock saw a decline on Monday, while Eli Lilly stock reached a new high following the announcement by Amgen that its experimental weight-loss drug demonstrated sustained results for up to 150 days. In a study conducted by Amgen, patients received the same dosage of the weight-loss drug three times. At the highest dose, they experienced an average 8.2% reduction in body weight over 92 days. This is in comparison to the …

Read more